Status:
COMPLETED
Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Breast Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal ca...
Detailed Description
This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber...
Eligibility Criteria
Inclusion
- Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate.
- Group A
- BIPOC (Black, Latinx, Native American or Pacific Islander)
- LEP Spanish-speaking (As indicated by the EHR)
- Low SES (from zip code with median household income \<$32,000/year) OR
- Age 70+
- Group B
- Any one NPIQ response indicating SDoH need
- Health literacy/numeracy, Caregiving/relationships, OR Finances
Exclusion
- \- Group A and B
- \-- Patients not continuing care at Dana Farber Cancer Institute
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04879927
Start Date
May 17 2021
End Date
April 1 2023
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215